Congenital heart block: Clinical Trials

7 trials for Congenital heart block, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown. 1 Early Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Not applicable1Completed 1
Phase 21Completed 1

Follow Congenital heart block: new trials by email Literature Review of Congenital heart block trials Research Report on Congenital heart block

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms
genetic blood analysis - Congenital Complete Heart Block, Cardiac Conduction Defect Progressive
UnknownNantes University Hospital26002011-01-012021-09-09
Preventive Approach to Congenital Heart Block With Hydroxychloroquine
Hydroxychloroquine - Congenital Heart Block, Neonatal Lupus
Phase 2CompletedNYU Langone Health742011-01-012021-02-25
The Research Registry for Neonatal Lupus
No intervention; observational - Neonatal Lupus, Systemic Lupus Erythematosus
CompletedNYU Langone Health1002010-05-272023-08-03
Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular Block
Congenital Complete Atrioventricular Heart Block, High Grade Atrioventricular Block
UnknownUniversity of Sao Paulo1402007-11-012013-05-07
Preventive IVIG Therapy for Congenital Heart Block
intravenous immune globulin (IVIG) - Congenital Heart Block, Neonatal Lupus
Early Phase 1CompletedNYU Langone Health202007-04-012019-09-30
Exercise in Chronically Paced Children
Congenital Diseases, Complete Heart Block
CompletedEmory University252007-01-012012-06-01
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
Dexamethasone or other corticosteroid - Congenital Heart Block, Neonatal Lupus
Not applicableCompletedNYU Langone Health1502000-10-012016-03-11

Narrower conditions

Neonatal Systemic lupus erythematosus (4)  ·  Lupus Erythematosus, Systemic (3)  ·  Sjogren's Syndrome (3)  ·  Autoimmune Diseases (2)  ·  Bundle-Branch Block (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Heart Failure (1)

Broader conditions

Arthritis (3)  ·  Arthritis, Rheumatoid (3)  ·  Connective Tissue Diseases (3)  ·  Dry Eye Syndromes (3)  ·  Eye Diseases (3)  ·  Immune System Diseases (3)  ·  Joint Diseases (3)  ·  Lacrimal Apparatus Diseases (3)  ·  Mouth Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Rheumatic Diseases (3)  ·  Salivary Gland Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Stomatognathic Diseases (3)  ·  Xerostomia (3)

Interventions

Dexamethasone (1)  ·  Hydroxychloroquine (1)  ·  Immunoglobulins, Intravenous (1)

Sponsors

NYU Langone Health (4)  ·  Emory University (1)  ·  Nantes University Hospital (1)  ·  University of Sao Paulo (1)

Countries

United States (5)  ·  Brazil (1)  ·  France (1)

Top investigators

Jill P. Buyon, MD (2)  ·  Jill P Buyon, MD (1)  ·  Jill P. Buyon (1)  ·  Patricio A Frias, MD (1)  ·  Roberto Costa, MD, PhD (1)  ·  Roberto M Oliveira Jr, MD (1)

Results publications

PMID 18195175, PMID 20391423, PMID 32674792, PMID 32907357

NIH funding

R01AR046265 (1)